Galadlas, Sarah Jane D.

HRN: 05-17-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
METRONIDAZOLE 500MG (TAB)
04/02/2024
04/08/2024
PO
1 Tab
TID
Thickly Msaf
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: